Orchid Chemicals and Pharmaceuticals Ltd

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. IDT opens molecular biology research facility in Redwood City Dr Caifu Chen to lead new product development at California site
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  5. Discover a new standard in self-priming pump technology Alfa Laval offers hygienic pumping with more efficiency and less noise

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

Hospira completes purchase of Orchid\'s API manufacturing and R&D facility

US$218m acquisition paves way for future development
Pharmaceutical

Indian manufacturers set to cash in on US generics market

Indian pharma companies are well positioned to generate strong revenues from the US generics market
Pharmaceutical

New anti-infectives company formed

Allecra Therapeutics to develop novel antibiotics to combat multi drug-resistant bacterial infections
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Mega deals and job cuts

Mergers and acquisitions, job cuts as companies streamlined their operations and cut costs, and investments in new plants were the main features of the pharmaceutical industry in 2012
Ingredients

Hospira to buy API manufacturing and r&d facilities in India

Purchase from Orchid will support continuity of antibiotic API supply
Finance

Hospira completes acquisition of Orchid's generic injectables business

Gains new manufacturing capabilities and expands global reach
Subscribe now